Sharyn Alfonsi reports on the unusual path fluvoxamine, a drug commonly used to treat obsessive-compulsive disorder, has had to becoming an early treatment candidate for COVID-19
Study indicates the drug is effective in opioid users who also take benzodiazepines for anxiety, other conditions
$5 million grant to fund saliva tests for students, teachers, staff in schools operated by Special School District of St. Louis County
Antidepressant drug repurposed for patients with coronavirus infection
Multi-university study shows app can help students reduce symptoms, ease depression
In 2019, the FDA approved Spravato for patients with major depressive disorder who hadn’t responded to other treatments. Now, the agency is adding patients who are having suicidal thoughts or have recently attempted to harm themselves or take their own lives.
Research focuses on precisely how the disease develops in the brain
Compelled by the potential to improve the lives of vulnerable children, emeritus trustee Walter Metcalfe and his wife, Cynthia, have committed nearly $4 million through outright and estate gifts to support the work of Joan L. Luby, MD, a highly regarded child psychiatrist.
Personalized brain maps could improve treatment for Parkinson’s disease, other neurological conditions
Researchers at Washington University School of Medicine in St. Louis have received a five-year, $11.5 million grant to lead a multicenter effort to understand how brain development in babies with Down syndrome differs from that in other babies.